Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Albert Dimeo

Thoracic Surgery (Cardiothoracic Vascular Surgery) Roslyn, NY Medical Doctor

NPI 1922080050 CMS profile 87217

100 Port Washington Blvd, Suite G01, Roslyn, NY 11576

Open in the dashboard

General payments

$55,220

561 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$58,386 paid to institutions, not to them · program year 2024

Through program year 2025, Albert Dimeo of Roslyn, NY is reported in the CMS Open Payments database as having received $55,220 across 561 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $58,386 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $25,252 131
2024 General $5,632 77
2023 General $4,781 83
2022 General $5,995 80
2021 General $4,719 73
2020 General $4,110 54
2019 General $4,731 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Albert Dimeo
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Albert Dimeo were reported at $25,252. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Albert Dimeo Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,731 $886 $178–$3,167 $163
2020 $4,110 $341 $108–$1,605 $114
2021 $4,719 $453 $125–$1,886 $132
2022 $5,995 $695 $180–$2,566 $149
2023 $4,781 $745 $205–$2,662 $160
2024 $5,632 $799 $214–$2,967 $164
2025 $25,252 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $20,780 91 payments
  2. Abbott Laboratories $10,187 153 payments
  3. Edwards Lifesciences Corporation $9,781 155 payments
  4. Atricure, Inc. $4,344 46 payments
  5. Medtronic Vascular, Inc. $2,302 28 payments
  6. Intuitive Surgical, Inc. $2,141 13 payments
  7. Zimmer Biomet Holdings, Inc. $1,140 9 payments
  8. Abiomed $1,134 16 payments
  9. Kestra Medical Technology Services, Inc. $842 14 payments
  10. Baxter Healthcare $302 3 payments
  11. Other $2,268 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $38,370 543 payments
  2. Travel and Lodging $13,826 17 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,025 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $14,225 56 payments
  2. Penditure $4,236 9 payments
  3. SAPIEN 3 Ultra RESILIA $2,860 57 payments
  4. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $2,392 34 payments
  5. ATRICLIP LAA EXCLUSION SYSTEM $2,315 22 payments
  6. Da Vinci Surgical System $2,141 13 payments
  7. SYNERGY ABLATION SYSTEM $1,746 17 payments
  8. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $1,294 15 payments
  9. Quadra Assura CRT Defibrillator $1,220 13 payments
  10. INSPIRIS RESILIA aortic valve $971 9 payments
  11. Other $22,181 310 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$466,890

Medicare's payments for the services billed

Medicare patients

295

Average age 76

Services billed

909

94 women, 201 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 59%
Arthritis 54%
Diabetes 48%
Heart failure 44%
Chronic kidney disease 33%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $32
$32 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

561 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record